Brief: Grifols' Biotest Launches Immunodeficiencies Medicine Yimmugo In U.S.
09/10/2025 16:38
Oct 9 (Reuters) - Grifols SA GRLS.MC: GRIFOL'S UNIT BIOTEST LAUNCHES YIMMUGO IN THE UNITED STATES Source text Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Grifols SA
See all newsSpanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12